Oncology & Hematology Coding Alert

READER QUESTIONS:

Why You Can't Always Expect Payment for Decadron

Question: Medicare has been denying our therapeutic push claims (90784). We use the drug Decadron during a chemotherapy session. Previously, we billed chemotherapy pushes (96408) for the Decadron, but I thought this was incorrect since it is not an anti-neoplastic drug. We can we do?

Georgia Subscriber Answer: Although Decadron is not a chemotherapeutic agent, many practices use the drug in cancer care to manage side effects and to treat the cancer itself. When the physician or nurse provides a Decadron injection, you may report 90784 (Therapeutic, prophylactic or diagnostic injection [specify material injected]; intravenous); however, insurers won't pay for the injection if your oncologist or nurse is also administering chemotherapy.

If the physician or nurse provides Decadron prior to or subsequent to the chemotherapy administration on the same day, you may use 90784-59 (... injection; distinct procedural service). Another thing to remember is that you can't report 90784 and 99211 (Office or other outpatient visit ...), according to Medicare guidelines.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All